共 50 条
- [31] Retrospective Study on endocrine Side Effects after Immunocombination Therapy with Ipilimumab and Nivolumab JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 91 - 91
- [32] DANAZOL THERAPY FOR CHRONIC IMMUNE-MEDIATED THROMBOCYTOPENIC PURPURA IN A PATIENT WITH COMMON VARIABLE IMMUNODEFICIENCY AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1991, 13 (03): : 326 - 329
- [35] Single Application of Ipilimumab and Nivolumab followed by Treatment Discontinuation due to severe immune-mediated Side Effects with Multi-organ Involvement and persistent complete Remission JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 56 - 56
- [37] Immune-mediated eosinophilic Fasciitis under Immune Checkpoint Blockade and the Intolerability of targeted Therapy in Patient with metastatic Melanoma JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 54 - 54
- [39] Time-delayed Onset of acute immune-mediated Liver Injury and interstitial Nephritis in a Patient with malignant Melanoma after a single Dose of Pembrolizum JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 93 - 93